Orange Book product · Generic (ANDA)
CANAGLIFLOZIN
CANAGLIFLOZIN
Generic (ANDA)ANDA 210386DISCN AUROBINDO PHARMA LTD
At a glance
Apr 20, 2026
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 20, 2026
2 mo ago
Today
Pharmaceutical detail
Active ingredient
CANAGLIFLOZIN
Strength
100MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 210386
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CANAGLIFLOZIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
